Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issues
This issue
15-1
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
15-1
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Journals
Journal #590
advertisement
Molecular Vision
4
Showing records 1 to 4 |
Display all abstracts in
Molecular Vision
53085
Review: Epigenetic mechanisms in ocular disease
He S; Li X; Chan N; Hinton DR
Molecular Vision
2013; 19: 665-674
52501
Development of novel LOXL1 genotyping method and evaluation of LOXL1, APOE and MTHFR polymorphisms in exfoliation syndrome/glaucoma in a Greek population
Chiras D; Tzika K; Kokotas H; Oliveira SC; Grigoriadou M; Kastania A; Dima K; Stefaniotou M; Aspiotis M; Petersen MB; Kroupis C; Kitsos G
Molecular Vision
2013; 19: 1006-1016
53097
Altered expression of transforming growth factor beta 1 and matrix metalloproteinase-9 results in elevated intraocular pressure in mice
Robertson JV; Siwakoti A; West-Mays JA
Molecular Vision
2013; 19: 684-695
53024
Roles of tumor necrosis factor alpha gene polymorphisms, tumor necrosis factor alpha level in aqueous humor, and the risks of open angle glaucoma: a meta-analysis
Xin X; Gao L; Wu T; Sun F
Molecular Vision
2013; 19: 526-535
Issue
15-1
Table of Contents
Editor's Selection
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept